 
 
 
 
September  14, 2023 
 
To, 
National Stock Exchange of India Limited  
 
BSE Limited  
Exchange Plaza 
 
 
 
 
Phiroze Jeejeeboy Towers 
Bandra Kurla Complex,  
 
 
 
 Dalal Street, 
Bandra (E), Mumbai - 400 051 
 
 
 Mumbai- 400 001 
(SYMBOL: THYROCARE) 
 
 
 
(SCRIP CODE 539871) 
 
Sub: Submission of Business Responsibility and Sustainability Report for the 
Financial Year 2022-23 
 
Dear Sir/Madam, 
 
Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing 
Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed 
herewith the Business Responsibility and Sustainability Report (BRSR) for the Financial 
Year 2022-23. 
 
We request you to please take the same on record. 
 
Thanking You 
Yours faithfully,  
 
For Thyrocare Technologies Limited 
 
 
Ramjee Dorai 
Company Secretary and Compliance Officer  
 
Dorai 
Ramjee
Digitally signed by 
Dorai Ramjee 
Date: 2023.09.14 
13:06:28 +05'30'
BUSINESS RESPONSIBILITY & 
SUSTAINABILITY REPORT
SECTION A- GENERAL DISCLOSURES
I.	
Details of the Company
	
1.	
Corporate Identity Number (CIN) of the Listed Entity: L85110MH2000PLC123882
	
2.	
Name of the listed entity: Thyrocare Technologies Limited
	
3.	
Year of incorporation: 2000
	
4.	
Registered Office Address: D-37/1, TTC Industrial Area, MIDC, Turbhe, Navi Mumbai-400703.
	
5.	
Corporate Address: D-37/3, TTC Industrial Area, MIDC, Turbhe, Navi Mumbai-400703.
	
6.	
E-mail: investor_relations@thyrocare.com
	
7.	
Telephone: 0124-2290427/28
	
8.	
Website: www.thyrocare.com
	
9.	
Financial year for which reporting is being done: April 2022- March 2023 (FY 2022-23)
	
10.	 Name of the Stock Exchange(s) where shares are listed: National Stock Exchange of India Limited and BSE Limited
	
11.	 Paid-up Capital: ` 52,93,00,430/-
	
12.	 Name and contact details (telephone, email address) of the person who may be contacted in case of any 
queries on the BRSR report:
	
	
Name: Ramjee Dorai
	
	
Designation: Company Secretary and Compliance Officer
	
	
Telephone No: 022-27622762
	
	
E-mail: ramjee.d@thyrocare.com
	
13.	 Reporting boundary - Are the disclosures under this report made on a standalone basis (i.e. only for the entity) 
or on a consolidated basis (i.e. for the entity and all the entities which form a part of its consolidated financial 
statements, taken together)
	
	
The disclosures under this report are made on standalone basis, However, Nueclear Healthcare Limited participates 
in the BRSR initiatives of the Company by adhering to the basic principles and practices of the Parent company, to 
the extent applicable
II.	
Product/ Services
	
14.	 Details of business activities (accounting for 90% of the turnover):
S. no.
Description of main activity
Description of business activity
% of turnover of the entity
1
Human health and social care 
services
Independent Diagnostics Laboratories
100
	
15.	 Products/Services sold by the entity (accounting for 90% of the entity’s turnover):
S.no.
Product/Service
NIC Code
% of total turnover contributed
1
Independent Diagnostics Laboratories
869
98.89%
2
Point of Care Testing devices and 
strips
325
1.11%
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
87
III.	 Operations
	
16.	 Number of locations where plants and/or operations/offices of the entity are situated:
Location
Number of plants 
Number of offices / labs 
Total 
National 
Not Applicable, as the company is in the 
business of providing diagnostic services.
31 
(including 3 COVID labs)
31
International
0
0
	
17.	
Markets served by the entity:
	
	
a.	
Number of locations
Locations
Number
National (No. of States)
26 States & 6 Union Territories
International (No. of Countries)
0
	
	
b.	
What is the contribution of exports as a percentage of the total turnover of the entity? 
	
	
	
Nil
	
	
c.	
A brief on type of customers
	
	
	
The Company’s customers include individual patients, other healthcare practitioners, hospitals and 
corporate customers.
IV.	 Employees
	
18.	 Details as on 31st March 2023:
	
	
a.	
Employees and workers
S. No. Particulars
Total (A)
Male
Female
No. (B)
% (B/A)
No. (C)
% (C/A)
Employees
1.
Permanent employees (D)
1645
1264
77%
381
23%
2.
Other than permanent employees (E)
0
0
0%
0
0%
3.
Total employees (D+E)
1645
1264
77%
381
23%
4.
Permanent workers (F)
0
0
0
0
0
5.
Other than permanent workers (G)
0
0
0
0
0
6.
Total Workers (F+G)
0
0
0
0
0
	
	
b.	
Differently abled Employees and workers:
S. No. Particulars
Total (A)
Male
Female
No. (B)
% (B/A)
No. (C)
% (C/A)
Differently Abled Employees
1.
Permanent (D)
3
3
100%
0
0
2.
Other than permanent (E)
0
0
0%
0
0
3.
Total employees (D+E)
3
3
100%
0
0
Differently abled workers
4.
Permanent (F)
-
-
-
-
-
5.
Other than permanent (G)
-
-
-
-
-
6.
Total Workers (F+G)
-
-
-
-
-
	
19.	 Participation/ Inclusion/ Representation of women
Total (A)
Number of Female (B)
Percentage (B/A)
Board of Directors
8
1
12.5
Key Management Personnel
3
0
0
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
88
	
20.	 Turnover rate for permanent employees and workers (Disclose trends for the past 3 years)
FY 2022-23
FY 2021-22
FY 2020-21
Male
Female
Total
Male
Female
Total
Male
Female
Total
Permanent employees
43.07%
59.26%
47.30%
43.58%
57.79%
47.84%
59.26%
47.30%
43.58%
Permanent workers
-
-
-
-
-
-
-
-
-
V.	
Holding, Subsidiary and Associate Companies (including joint ventures)
	
21.	 (a)	 Names of holding / subsidiary / associate companies / joint ventures
S. No. Name of the holding / subsidiary / 
associate companies / joint ventures 
(A)
Indicate whether 
holding/ Subsidiary/ 
Associate/ Joint 
Venture
% of shares 
held by 
listed entity
Does the entity indicated at 
column A, participate in the 
Business Responsibility 
initiatives of the listed entity? 
(Yes/No)
1
Docon Technologies Private Limited
Holding
71.14
No
2
Nueclear Healthcare Limited
Subsidiary
100
Yes*
3
Pulse Hitech Health Services 
(Ghatkopar) LLP
Subsidiary
51
No
4
Equinox Labs Private Limited
Associate
30
No
	
	
     * Nueclear Healthcare Limited participates in the BRSR initiatives of the Company by following the basic principles and 
practices of the Parent company, to the extent applicable.
VI.	 CSR Details
	
22.	 (i)	
Whether CSR is applicable as per section 135 of Companies Act, 2013 (Yes/No): Yes
	
	
(ii)	 Turnover (in `): 4,86,46,35,303/-
	
	
(iii)	 Net worth (in `): 5,20,75,89,261/-
VII.	 Transparency and Disclosures Compliances
	
23.	 Complaints/Grievances on any of the principles (Principles 1 to 9) under the National Guidelines on Responsible 
Business Conduct
Stakeholder 
group from 
whom 
complaint is 
received
Mechanism in Place (Yes/No) (If 
Yes, then provide web-link for 
grievance redress policy)
Current FY 2022-23
Previous FY 2021-22
Number of 
complaints 
filed during 
the year
Number of 
complaints 
pending 
resolution at 
close of the 
year
Remarks
Number of 
complaints 
pending 
resolution at 
close of the 
year
Number of 
complaints 
pending 
resolution at 
close of the 
year
Remarks
Communities
No
There weren’t any complaints / grievances received from any specific community
Investors 
(other than 
shareholders)
Yes, The Company has setup an 
investor grievance mechanism to 
respond to investor grievances in 
a timely and appropriate manner. 
The investor grievances and action 
taken are also reviewed.
Investors can reach out to the 
Company Secretary at https://
investor.thyrocare.com/investor-
contacts/
0
0
NA
0
0
NA
Shareholders
Shareholders, for any of their 
grievances can reach out to the 
Company Secretary at https://
investor.thyrocare.com/investor-
contacts/
3
0
NA
4
0
NA
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
89
Stakeholder 
group from 
whom 
complaint is 
received
Mechanism in Place (Yes/No) (If 
Yes, then provide web-link for 
grievance redress policy)
Current FY 2022-23
Previous FY 2021-22
Number of 
complaints 
filed during 
the year
Number of 
complaints 
pending 
resolution at 
close of the 
year
Remarks
Number of 
complaints 
pending 
resolution at 
close of the 
year
Number of 
complaints 
pending 
resolution at 
close of the 
year
Remarks
Employees 
and workers
Yes, 
the 
Company 
has 
an 
automated Grievance Redressal 
Mechanism 
for 
reporting 
and 
ensuring effective redressal of 
employee 
grievances. 
This 
is 
inbuilt in the HR tool named as 
Darwinbox, wherein any employee 
can raise and seek redressal of 
grievance. The grievances are 
reported to HR directly.
There is also a vigil mechanism in 
place to report serious grievances 
and 
inappropriate 
action 
by 
any 
other 
employee/executive/
director. The Internal Complainants 
Committee 
has 
also 
been 
constituted to look into complaints 
of sexual harassment, if any.
0
0
NA
0
0
NA
Customers
The Company has not implemented 
a formal Grievance Redressal 
Policy, however, customers can 
submit their complaints to the 
Company 
through 
following 
channels:
1)	 By 
writing 
an 
email 
to 
complaints@thyrocare.com;
2)	 By 
calling 
on 
the 
helpline 
numbers 
at 
022 
30900000/67123400; and
3)	 By sending a message through 
whatsapp on 9870666333.
Upon receiving a complaints, a 
ticket is generated and assigned 
to the relevant stakeholders group 
for redressal. Standard Turnaround 
Time (TAT) for closure a ticket is 24 
to 48 hours.
The escalation matrix for complaint 
redressal is as follows:
Level1: redressals@thyrocare.com;
Level2: gm.redressals@thyrocare.
com
After 
a 
complaint 
has 
been 
resolved, customers are requested 
to provide feedback on their 
satisfaction/ 
dissatisfaction 
regarding the compliant redressal 
through email. If a customer 
selects “Not-satisfied”, the ticket is 
re-opened and entire process will 
be followed again.
4929
16*
16 tickets 
were 
pending due 
to pending 
sample 
recollection 
and 
customer’s 
consent 
for sample 
recollection 
by the end of 
financial year 
on March 31, 
2023
4266
31**
31 tickets 
were 
pending due 
to pending 
sample 
recollection 
and 
customer’s 
consent 
for sample 
recollection 
by the end of 
financial year 
on March 31, 
2022
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
90
Stakeholder 
group from 
whom 
complaint is 
received
Mechanism in Place (Yes/No) (If 
Yes, then provide web-link for 
grievance redress policy)
Current FY 2022-23
Previous FY 2021-22
Number of 
complaints 
filed during 
the year
Number of 
complaints 
pending 
resolution at 
close of the 
year
Remarks
Number of 
complaints 
pending 
resolution at 
close of the 
year
Number of 
complaints 
pending 
resolution at 
close of the 
year
Remarks
Value Chain
Partners
The 
Company 
has 
not 
implemented a formal Grievance 
Redressal Policy, however, Value 
Chain Partners can raise concerns 
via email, post, telephone, or 
courier. (Email- support@thyrocare.
com, 
WhatsApp- 
8422888222, 
Phone - 022 38002350). Value 
chain partners of the Company 
comprises of sample collection 
centers across India.
19858
24*
The 
Company 
has 
introduced 
ticket based 
complaint 
system in FY 
22-23 which 
helped in 
increasing 
efficiency for 
compliant 
redressal. 24 
complaints 
were 
pending as 
on March 
31, 2023 on 
account of 
confirmation 
awaited from 
the clients 
and their 
customer’s 
for sample 
recollection.
-
-
The 
Company 
has not 
developed 
a formal 
compliant 
recording 
mechanism 
for its value 
chain 
partners 
during FY 
2021-22. 
However, 
such 
grievances 
were 
generally 
reported 
through the 
employees/
department 
with whom 
they co-
ordinate 
during FY 
2021-22
Others 
(please 
specify)
-
-
-
-
-
-
-
	
	
     *All complaints are closed as on April 15, 2023
	
	
     ** All complaints are closed as on April 20, 2022
	
24.	 Overview of the entity’s material responsible business conduct issues.
	
	
Please indicate material responsible business conduct and sustainability issues pertaining to environmental and 
social matters that present a risk or an opportunity to your business, rationale for identifying the same, approach to 
adapt or mitigate the risk along-with its financial implications, as per the following format
S. No. Material issue 
identified
Indicate 
whether risk 
or opportunity 
(R/O)
Rationale for 
identifying the risk / 
opportunity
In case of risk, approach to 
adapt or mitigate
Financial implications of 
the risk or opportunity 
(Indicate positive or 
negative implications)
1.
Competition
Risk
Threat to market share
Market research to stay 
updated on competitors’ 
activities, customer service, 
branding
2.
Alternate Energy & 
Environment 
Conservation-
Solar panels
Opportunity
Provide a renewable, 
sustainable and cost-
effective source of 
energy
-
NA
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
91
S. No. Material issue 
identified
Indicate 
whether risk 
or opportunity 
(R/O)
Rationale for 
identifying the risk / 
opportunity
In case of risk, approach to 
adapt or mitigate
Financial implications of 
the risk or opportunity 
(Indicate positive or 
negative implications)
3.
Financial Risk
Risk
Market risk, credit 
risk, Operational risk, 
Liquidity risk
Risk management 
strategies, diversifying 
investments, maintaining 
financial reserves, securing 
insurance coverage and 
conducting regular audits 
and assessments
Financial losses, 
increased borrowing 
costs or reduced liquidity
4.
Cyber Security
Risk
Cyber threat as data 
volumes grow
Implementing robust 
cybersecurity measures, 
such as firewalls, encryption, 
regular security audits, 
employee training on best 
practices and incident 
response plans
Financial losses, legal 
liabilities, reputational 
damage, and potential 
regulatory fines
5.
Human Resource
Risk/
Opportunity
Attract & retain key 
talent and health, 
safety & well-being of 
human resource
Competitive compensation 
and providing professional 
development opportunities, 
fostering a positive work 
environment, and prioritizing 
employee health and safety
Attracting and retaining 
key talent or addressing 
health and safety issues 
may result in increased 
recruitment and 
training costs, reduced 
productivity
SECTION B- MANAGEMENT AND PROCESS DISCLOSURES
P1 - Businesses should conduct and govern themselves with integrity, and in a manner that is Ethical, Transparent 
and Accountable
P2 - Businesses should provide goods and services in a manner that is sustainable and safe
P3 - Businesses should respect and promote the well-being of all employees, including those in their value chains.
P4 - Businesses should respect the interests of and be responsive to all its stakeholders.
P5 - Businesses should respect and promote human rights
P6 - Businesses should respect and make efforts to protect and restore the environment.
P7 - Businesses, when engaging in influencing public and regulatory policy, should do so in a manner that is responsible 
and transparent.
P8 - Businesses should promote inclusive growth and equitable development.
P9 - Businesses should engage with and provide value to their consumers in a responsible manner.
Disclosure Questions
P1
P2
P3
P4
P5
P6
P7
P8
P9
Policy and management processes
1.	
a.	
Whether your entity’s policy/policies cover each 
principle and its core elements of the NGRBCs. (Yes/
No)
Y
Y
Y
Y
Y
Y
Y
Y
Y
	
b.	
Has the policy been approved by the Board? (Yes/
No)
Y
Y
Y
Y
Y
Y
Y
Y
Y
	
c.	
Web Link of the Policies, if available
Investor Relations (thyrocare.com)
2.	
Whether the entity has translated the policy into 
procedures. (Yes / No)
Y
Y
Y
Y
Y
Y
Y
Y
Y
3.	
Do the enlisted policies extend to your value chain 
partners? (Yes/No)
The Company encourages adoption of Business responsibility 
initiatives by its Business Associates and value chain partners to the 
extent feasible.
4.	
Name 
of 
the 
national 
and 
international 
codes/
certifications/labels/ standards (e.g. Forest Stewardship 
Council, Fairtrade, Rainforest Alliance, Trustea) standards 
(e.g. SA 8000, OHSAS, ISO, BIS) adopted by your entity 
and mapped to each principle.
NA
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
92
Disclosure Questions
P1
P2
P3
P4
P5
P6
P7
P8
P9
5.	
Specific commitments, goals and targets set by the entity 
with defined timelines, if any.
The Company is committed to implementing the course of action 
envisioned under the 9 principles defined in the National Voluntary 
Guidelines on Social, Environmental & Economic Responsibilities of 
Business which is issued by the Ministry of Corporate Affair.
6.	
Performance 
of 
the 
entity 
against 
the 
specific 
commitments, goals and targets along-with reasons in 
case the same are not met
The Company will continue to track its performance against the said 
principle(s) and take mandatory actions whenever needed.
Governance, leadership and oversight
7.	
Statement by director responsible for the business responsibility report, highlighting ESG related challenges, targets and 
achievements
	
The ESG (Environmental, Social, and Governance) paradigm is of paramount importance, given the industry in which our company 
operates. We recognize the need to thrive within our immediate environment in which we operate responsibly by implementing 
sustainable practices.
	
Since its inception, our company has persistently launched various initiatives to amplify ESG-based practices and make successful 
headways in various verticals. Till date, key issues have been successfully addressed, including proper disposal and treatment of 
bio-medical waste, water conservation by implementing water-saving reducers, transitioning to e-billing to reduce paper usage and 
adoption of solar panels.
	
The Company has invested in Effluent treatment plants for its labs and Sewage treatment plants at its Head office to ensure both the 
lab waste water as well the general waste water is adequately treated before its discarded through the drain lines.
	
The Company also plans to invest in the organic waste compost plants to treat and reuse its dry and wet general waste.
	
Additionally, majority of the communications, messaging and announcements to our channel partners is now being done digitally 
instead of using traditional physical collaterals.
	
Our company is cognizant of its ethical responsibilities as a corporate citizen and continuously acts in adherence to moral principles.
8.	
Details 
of 
the 
highest 
authority 
responsible 
for 
implementation 
and 
oversight 
of 
the 
Business 
Responsibility policy (ies).
Mr. Rahul Guha,
Managing Director and Chief Executive Officer (Executive Director)
DIN: 09588432
Tel: 022-2762 2762
Email Id: investor_relations@thyrocare.com
9.	
Does the entity have a specified Committee of the Board/ 
Director responsible for decision making on sustainability 
related issues? (Yes / No). If yes, provide details.
Implementation of the Policy would be governed by the Corporate 
Social Responsibility Committee headed by an Independent Director.
10. 	 Details of Review of NGRBCs by the Company:
Subject for Review
Indicate whether review was undertaken by 
Director / Committee of the Board/ Any other 
Committee
Frequency (Annually/ Half yearly/ Quarterly/ 
Any other – please specify)
P1
P2
P3
P4
P5
P6
P7
P8
P9
P1
P2
P3
P4
P5
P6
P7
P8
P9
Performance against above 
policies and follow up action
No
Compliance with statutory 
requirements of relevance to the 
principles, and, rectification of any 
non-compliances
No
11.	
Has the entity carried out independent assessment/ evaluation of the working of its policies by an external agency? (Yes/No). 
If yes, provide name of the agency.
P1
P2
P3
P4
P5
P6
P7
P8
P9
N
N
N
N
N
N
N
N
N
12.	
If answer to question (1) above is “No” i.e. not all Principles are covered by a policy, reasons to be stated:
	
The entity does not consider the Principles material 
to its business (Yes/No)
Not applicable
	
The entity is not at a stage where it is in a position to 
formulate and implement the policies on specified 
principles (Yes/No)
	
The entity does not have the financial or/human and 
technical resources available for the task (Yes/No)
	
It is planned to be done in the next financial year 
(Yes/No)
	
Any other reason (please specify)
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
93
SECTION C- PRINCIPAL WISE PERFORMANCE DISLOSURE
PRINCIPLE 1: Businesses should conduct and govern themselves with integrity, and in a manner that is 
ethical, transparent, and accountable
Thyrocare believes that Ethics, Transparency and Accountability are inter-related:- a business which runs its operations ethically 
and in a transparent manner, would never have any problem of Accountability towards all its stakeholders, and to the society at 
large. Thyrocare has been conducting its business on Ethical lines, and in a transparent manner from the day of its inception. 
Thyrocare has formulated an elaborate code of conduct, which is applicable to all the Directors and the employees of the 
Company and its subsidiary(ies). The Company has also put in place a Whistle-Blower policy to enable employees to report any 
actual or suspected incidence of corruption, bribery, or any kind of unethical behaviour on the part of any employee, including 
executives and directors. The Code of Conduct and the Whistle Blower Policy have been uploaded on the Company’s website.
1.	
Percentage coverage by training and awareness programmes on any of the principles during the financial year:
Segment
Total number of 
training and awareness 
programmes held
Topics / principles covered 
under the training and its 
impact
%age of persons in respective 
category covered by the 
awareness programmes
Board of Directors
1
Familiarization programs
100%
Key Managerial Personnel
1
Code of conduct/ Behavioural
100%
Employees other than BoDs and KMPs
54
Basic Safety Training
100 %
Workers
NA
NA
NA
2.	
Details of fines / penalties /punishment/ award/ compounding fees/ settlement amount paid in proceedings (by the 
entity or by directors / KMPs) with regulators/ law enforcement agencies/ judicial institutions, in the financial year:
Monetary
NGRBC 
Principle
Name of the Regulatory/ 
enforcement agencies/ judicial 
institutions
Amount (in 
INR.)
Brief of Case
Has an appeal 
been preferred? 
(yes/ No)
Penalty/ Fine
NIL
-
-
-
-
Settlement
NIL
-
-
-
-
Compounding Fee
NIL
-
-
-
-
Non-Monetary
Imprisonment
NIL
-
-
-
-
Punishment
NIL
-
-
-
-
3.	
Of the instances disclosed in Question 2 above, details of the Appeal/ Revision preferred in cases where monetary 
or non-monetary action has been appealed:
Case Details
Name of the regulatory/ enforcement agencies/ judicial institutions
N.A.
N.A.
4.	
Does the entity have an anti-corruption or anti-bribery policy? If yes, provide details in brief and if available, provide 
a web-link to the policy:
	
Thyrocare’s code of conduct contains guidelines on anti-bribery and anti-corruption. The policy is available on the 
company’s website at https://investor.thyrocare.com/wp-content/uploads/2023/01/Code-of-conduct-1.pdf
5.	
Number of Directors/KMPs/employees/workers against whom disciplinary action was taken by any law for the 
charges of bribery/ corruption:
Current Financial Year 2022-23
Previous Financial Year 2021-22
Directors 
None
None
Key Managerial Personnel (KMPs) 
None
None
Employees 
None
None
Workers 
N.A.
N.A.
Essential Indicators
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
94
6.	
Details of complaints with regard to conflict of interest:
Current Financial Year 2022-23
Previous Financial Year 2021- 22
Number
Remark
Number
Remark
Number of complaints received in relation to issues of 
Conflict of Interest of the Directors
None
-
None
-
Number of complaints received in relation to issues of 
Conflict of Interest of the KMPs
None
-
None
-
7.	
Provide details of any corrective action taken or underway on issues related to incide / penalties / action taken by 
regulators/ law enforcement agencies/ judicial institutions, on cases of corruption and conflicts of interest – Not 
applicable
Leadership Indicators 
1.	
Awareness programmes conducted for value chain partners on any of the principles during the financial year
Total number of awareness programmes 
held
Topics/ Principles 
covered under the 
training
%age of value chain partners covered (by value of 
business done with such partners) under the awareness 
programmes
As of now, the Company has not conducted any awareness programs for value chain partners as the policies apply only to the 
Company as of now. However, the Company shall strive to initiate the awareness program going forward based on materiality.
2.	
Does the entity have processes in place to avoid/ manage conflict of interests involving members of the Board? 
(Yes/No) If Yes, provide details of the same.
	
Yes, The Company receives an annual declaration from its Board members and Key Managerial Personnel on the entities 
they are interested in and ensures requisite approvals as required under the statute as well as the Company’s policies 
are in place before transacting with such entities / individuals. Further, there is a code of conduct applicable to board of 
directors and senior management which deals with the aspect of conflict of interest. This Code of conduct is available on 
the website of the Company. Also, a declaration signed by the Managing Director that the members of board of directors 
and senior management personnel have affirmed compliance with the code of conduct applicable to board of directors 
and senior management, is forming part of the corporate governance report.
PRINCIPLE 2: Businesses should provide goods and services in a manner that is sustainable and safe
Essential Indicators 
Thyrocare believes that for a diagnostic service oriented company like it, sustainability means providing dependable results at 
affordable cost. With this in view, Thyrocare established India’s first fully automated and IT-enabled laboratory that today ensures 
error-free processing of specimens collected from all over India and sent by using an innovative air-cargo system, and giving 
results within a reasonable turnaround time, by employing the latest technologies, and fully computerised testing process, 
Thyrocare is able to remain at par with industry standards in terms of quality and service delivery. By handling huge volumes, 
Thyrocare is able to provide its services at the lowest possible cost, unmatched by any other service provider in the industry.
1.	
Percentage of R&D and capital expenditure (capex) investments in specific technologies to improve the 
environmental and social impacts of product and processes to total R&D and capex investments made by the 
entity, respectively.
Current Financial Year 
(2022-2023)
Previous Financial Year 
(2021-2022)
Details of improvements in environmental 
and social impacts
R&D
Capex
3.36%
16.4%
Investments in Solar panels, Effluent treatment 
plants, Sewage treatment plants and Autoclave 
at various labs
2.	
i.	
Does the entity have procedures in place for sustainable sourcing? (Yes/No)
	
	
Yes, the Company is committed towards sustainable business practices and hence, while onboarding any supply chain 
partners, the Company evaluates the partners on the basis of their commitment towards social and environmental 
parameters like, child labour, human rights and environment safety. The Company also prefers doing business with 
supply chain partners who are committed towards environmental safety standards.
	
	
ii.	
If yes, what percentage of inputs were sourced sustainably?
	
	
	
The value / percentage of inputs sourced sustainably, is not tracked by the Company at present.
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
95
3.	
Describe the processes in place to safely reclaim your products for reusing, recycling and disposing at the end of 
life,
	
Since the Company is in the business of providing diagnostic services, recycling or reusing products after they have 
served their purpose is not applicable. However, the Company has agreements with authorised vendors for the secure 
and timely disposal of biomedical waste created during the collection and testing of samples.
4.	
Whether Extended Producer Responsibility (EPR) is applicable to the entity’s activities (Yes / No). If yes, whether 
the waste collection plan is in line with the Extended Producer Responsibility (EPR) plan submitted to Pollution 
Control Boards? If not, provide steps taken to address the same
	
Not applicable.
Leadership Indicators 
1.	
Has the entity conducted Life Cycle Perspective / Assessments (LCA) for any of its products (for manufacturing 
industry) or for its services (for service industry)? If yes, provide details in the following format?
NIC 
Code
Name of 
Product /
Service
Product /Service 
% of total Turnover 
contributed
Boundary for which the 
Life Cycle Perspective 
/ Assessment was 
conducted
Whether conducted by 
independent external 
agency (Yes/No)
Results communicated 
in public domain (Yes/
No) If yes, provide the 
web-link.
None
2.	
If there are any significant social or environmental concerns and/or risks arising from production or disposal of 
your products / services, as identified in the Life Cycle Perspective / Assessments (LCA) or through any other 
means, briefly describe the same along-with action taken to mitigate the same.
Name of Product / Service
Description of the risk / concern
Action Taken
None
3.	
Percentage of recycled or reused input material to total material (by value) used in production (for manufacturing 
industry) or providing services (for service industry).
Indicate input material
whad or re-used input material to total material
Current Financial Year
(2021-2022)
Previous Financial Year
(2021-2022)
The Company is into the business of providing diagnostic services and hence it is not applicable.
4.	
Of the products and packaging reclaimed at end of life of products, amount (in tonnes) reused, recycled, and safely 
disposed, as per the following format:
Current Financial Year 
(2022-2023)
Previous Financial Year 
(2021-2022)
Re-Used
Recycled
Safely 
Disposed
Re-Used
Recycled
Safely 
Disposed
Plastics (including packaging)
NA
237.4 T
NA
NA
241.9 T
NA
E-waste
NA
NA
NA
NA
NA
NA
Hazardous waste
NA
NA
175.3 T
NA
NA
112.6 T
Other waste
NA
NA
NA
NA
NA
NA
5.	
Reclaimed products and their packaging materials (as percentage of products sold) for each product category.
Indicate product category
Reclaimed products and their packaging materials
as % of total products sold in respective category
NA
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
96
PRINCIPLE 3: Businesses should respect and promote the well-being of all employees, including those in 
their value chains
Essential Indicators 
Thyrocare is alive to the fact that Human Resources are the most valued assets of any organisation, and hence every organisation 
has to take all possible measures for the well-being of the employees, so as to keep their morale and motivation high. With 
this in view, Thyrocare has structured numerous welfare measures and is also taking necessary steps for enhancement of 
their skills and abilities on a continuous basis. Thyrocare organises recreational events like New Year celebrations and Get-
togethers, Townhall and periodical contests to enable the employees to exhibit their abilities. Thyrocare has also introduced 
Employees Stock Option Scheme whereby shares equivalent to about 1% of the Company’s paid up capital would be offered, 
over a period of time to all the eligible employees to inculcate into them a deep sense of belonging to the organisation, besides 
giving them an opportunity of sharing the benefit of the Company’s growth. Under this scheme, Thyrocare has already granted 
options to the eligible employees in the past eight years. Thyrocare takes utmost care of its employees’ safety & wellbeing. 
Strong norms & guidelines were set to ensure that employees are safe while in office & on field – Proper safety measures, such 
as the use of appropriate PPE including gloves, masks, and other necessary equipment, are strictly followed while handling 
and testing of patients’ samples.
1.	
a.	
Details of measures for the well-being of employees:
Category
% of employees covered by
Total 
(A)
Health 
insurance
Accident 
insurance*
Maternity 
benefits
Paternity 
Benefits
Day Care 
facilities
Number 
(B)
% (B / A)
Number 
(C)
% (C / A)
Number 
(D)
% (D / A)
Number 
(E)
% (E / A)
Number 
(F)
% (F / A)
Permanent employees
Male
1264
1264
100%
-
-
NA
NA
1264
100%
NA
NA
Female
381
381
100%
-
-
381
100%
NA
NA
NA
NA
Total
1646
1646
100%
-
-
381
100%
1264
100%
NA
NA
Other than Permanent employees
Male
-
-
-
-
-
-
-
-
-
-
-
Female
-
-
-
-
-
-
-
-
-
-
-
Total
-
-
-
-
-
-
-
-
-
-
-
	
	
    *The accident policy is taken for phlebotomists and Runners involved in sample logistics.
	
b.	
Details of measures for the well-being of workers: Not Applicable
Category
% of workers covered by
Total (A)
Health 
insurance
Accident 
insurance
Maternity 
benefits
Paternity 
Benefits
Day Care 
facilities
Number 
(B)
% (B / A)
Number 
(C)
% (C / A)
Number 
(D)
% (D / A)
Number 
(E)
% (E / A)
Number 
(F)
% (F / A)
Permanent workers
Male
-
-
-
-
-
-
-
-
-
-
-
Female
-
-
-
-
-
-
-
-
-
-
-
Total
-
-
-
-
-
-
-
-
-
-
-
Other than Permanent workers
Male
-
-
-
-
-
-
-
-
-
-
-
Female
-
-
-
-
-
-
-
-
-
-
-
Total
-
-
-
-
-
-
-
-
-
-
-
2.	
Details of retirement benefits, for Current Financial Year and Previous Financial Year.
Benefits
	
Current Financial Year 2022-23
Previous Financial Year 2021-22
No. of employees 
covered as a % of 
total employees
No. of workers 
covered as a % 
of total workers
Deducted and 
deposited with 
the authority 
(Y/N/N.A.)
No. of employees 
covered as a % of 
total employees
No. of workers 
covered as a % 
of total workers
Deducted and 
deposited with 
the authority 
(Y/N/N.A.)
PF
100%
NA
Y
100%
NA
Y
Gratuity
100%
NA
Y*
100%
NA
Y
ESI
46%
NA
Y
74%
NA
Y
  	
  *All eligible employees have been paid gratuity.
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
97
3.	
Accessibility of workplaces- Are the premises / offices of the entity accessible to differently abled employees and 
workers, as per the requirements of the Rights of Persons with Disabilities Act, 2016? If not, whether any steps are 
being taken by the entity in this regard.
	
The Company continues to strive to develop an inclusive environment for its entire workforce and does not differentiate 
between its employees basis physical capabilities. In that direction, the Company has made its offices accessible to 
persons with disabilities, wherever possible. Some of the initiatives taken by the Company towards this are as under:
	
- Increasing door width
	
- Hand grabs in restrooms
	
- Fire exist signs
	
- Ramps
	
- lift, etc
	
Further our organization does not discriminate based on physical ability for onboarding employees/workers and has an 
inclusive environment for persons with disabilities.
4.	
Does the entity have an equal opportunity policy as per the Rights of Persons with Disabilities Act, 2016? If so, 
provide a web-link to the policy:
	
The Company’s code of conduct emphasizes providing equal opportunities for employees at all levels and prohibits the 
discrimination or harassment. The policy is available on the Company’s website at https://investor.thyrocare.com/wp-
content/uploads/2023/06/Code-of-conduct-1-2.pdf
5.	
Return to work and Retention rates of permanent employees and workers that took parental leave.
Gender
Permanent employees
Permanent workers
Return to work rate
Retention rate
Return to work rate
Retention rate
Male
100%
100%
-
-
Female
100%
100%
-
-
Total
100%
100%
-
-
6.	
Is there a mechanism available to receive and redress grievances for the following categories of employees and 
worker? If yes, give details of the mechanism in brief.
Yes/No (If Yes, then give details of the mechanism in brief)
Permanent Workers
N.A.
Other than Permanent Workers
N.A.
Permanent Employees
Yes, the Company has an automated Grievance Redressal Mechanism for reporting 
and ensuring effective redressal of any kind of employee grievances. This is inbuilt 
in the HR tool, wherein any employee can raise and seek redressal for any of his/
her grievance. The grievances are reported to HR directly and the suitable matrix is 
followed for resolution of each grievance.
Other than Permanent Employees
-
7.	
Membership of employees and worker in association(s) or Unions recognised by the listed entity:
	
There is no employee association recognized by the Company
Category
Current Financial Year 2022-23
Previous Financial Year 2021-22
Total 
employees 
/ workers in 
respective 
category (A)
No. of employees / 
workers in respective 
category, who are 
part of association(s) 
or Union (B)
% (B / A)
Total 
employees 
/ workers in 
respective 
category (C)
No. of employees / 
workers in respective 
category, who are 
part of association(s) 
or Union (D)
% (D / C)
Total Permanent Employee
Male
1306
0
0
1466
0
0
Female
407
0
0
575
0
0
Total Permanent Workers
Male
-
-
-
-
-
-
Female
-
-
-
-
-
-
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
98
8.	
Details of training given to employees and workers:
Category
Current Financial Year 2022-23
Previous Financial Year 2021-22
Total (A)
On Health and 
safety measures
On Skill Upgradation
Total (D)
On Health and 
safety measures
On Skill Upgradation
No. (B)
% (B / A)
No. (C)
% (C / A)
No. (E)
% (E / D)
No. (F)
% (F / D)
Employees
Male
1264
553
42%
344
 26%
1466
601
41%
337
23%
Female
381
130
32%
65
16%
575
207
36%
63
11%
Total
1645
683
 40%
409
24%
2041
808
39%
400
19%
Workers
Male
0
0
0
0
0
0
0
0
0
0
Female
0
0
0
0
0
0
0
0
0
0
Total
0
0
0
0
0
0
0
0
0
0
9.	
Details of performance and career development reviews of employees and worker:
Category
Current Financial Year 2022-23
Previous Financial Year 2021-22
Total (A)
No. (B)
% (B / A)
Total (C)
No. (D)
% (D / C)
Employees
Male
1264
1264
100%
1466
1466
100%
Female
381
381
100%
575
575
100%
Total
1645
1645
100%
2041
2041
100%
Workers
Male
NA
NA
NA
NA
NA
NA
Female
NA
NA
NA
NA
NA
NA
Total
NA
NA
NA
NA
NA
NA
10.	  Health and safety management system:
	
a.	
Whether an occupational health and safety 
management system has been implemented by the 
entity? (Yes/ No). If yes, the coverage such system?
	
	
Yes, Occupational Health and Safety management 
system has been implemented by the Company. 
Following are some key practices that have been 
carried out:
	
	
-	
Monthly inspection of labs of the Company has 
been conducted.
	
	
-	
All the labs are under the Fire Annual 
Maintenance which includes maintenance and 
servicing of fire equipment’s on the premises
	
	
-	
Mock drill trainings are conducted every 
six months.
	
	
-	
Safety induction training is given to the 
new joinees.
	
	
-	
Personal Protection Equipment kits are 
provided to the employees deployed at labs, 
members of maintenance team and also for 
the ground staff.
	
	
-	
Daily inspection round in labs is carried out 
by the Housekeeping Incharge, Canteen 
Incharge and also by Maintenance team.
	
	
-	
Segregation of bio-medical waste is ensured 
as per the regulatory norms prescribed.
	
	
-	
First Aid boxes are available at suitable places 
which is regularly monitored and refilled.
	
	
-	
Regular Health and Wellness Camps are 
undertaken for employees.
	
	
-	
Monthly Safety training is given to the 
employees on the various safety topics such 
as: chemical handling, manual handling of 
Materials & equipment’s, electrical safety, first 
aid measures & Cardiopulmonary resuscitation 
(CPR).
	
b.	
What are the processes used to identify work-related 
hazards and assess risks on a routine and non-
routine basis by the entity?
	
	
Following are the processes followed by the 
Company for identification of work-related hazards:
	
	
-	
Programs and procedures are developed to 
identify the risks and hazards. The procedures 
are reviewed and updated regularly on the 
basis of any amendments to the applicable 
laws and regulations.
	
	
-	
Monitoring progress through periodic 
evaluations.
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
99
	
c.	
Whether you have processes for workers to report 
the work-related hazards and to remove themselves 
from such risks. (Y/N)
	
	
Yes, eligible employees undergo regular training 
to identify the hazards and learn how to mitigate 
the risks in accordance with the programs and 
procedures developed. If a hazardous incident 
occurs, reporting matrix is followed to report 
the incident.
	
d.	
Do the employees/ workers of the entity have 
access to non-occupational medical and healthcare 
services? (Yes/ No)
	
	
Yes, there is a proactive health and well-being 
initiative that takes care of the overall physical and 
mental well-being of employees. Additionally, the 
Company has ensured that all eligible employees 
are covered by ESIC insurance (Employee’s State 
Insurance Corporation). Further, all employees are 
covered for medical claims. Diagnostic tests are 
made available at discounted rate to our employees.
11.	 Details of safety related incidents, in the following format:
Safety Incidents/ Number
Category
Current Financial Year 2022-23
Previous Financial Year 2021-22
Lost Time Injury Frequency Rate (LTIFR) 
(per one million-person hours worked)
Employees
0
0
Workers
-
-
Total recordable work-related injuries
Employees
0
0
Workers
-
-
Number of fatalities
Employees
0
0
Workers
-
-
High consequence work-related injury or 
ill-health (excluding fatalities)
Employees
0
0
Workers
-
111
12.	 Describe the measures taken by the entity to ensure a safe and healthy workplace.
	
Following are the measures undertaken by the Company to ensure a safe and healthy workplace:
	
-	
Implementation of safety policies and safe operating procedure (SOP) across the organization.
	
-	
Conducting safety trainings and fire evacuation drills at regular intervals.
	
-	
Provision of Personal Protective Equipment Kits (PPE Kits) to staff including Hand gloves, Mask, Lab coats, goggles 
wherever it is required.
	
-	
Providing vaccination to all employees in Labs.
	
-	
Signages have been installed at sensitive areas for the benefit of the employees.
	
-	
Disinfection process is followed in labs regularly
	
-	
20 labs have received NABL accreditation and these labs also adhere to NABL standards.
	
-	
Segregation and disposal of bio-degradable waste in accordance with applicable laws.
13.	 Number of Complaints on the following made by employees and workers:
Current Financial Year 2022-23
Previous Financial Year 2021- 22
Filed
Pending Resolution at 
end of year
Remark
Filed
Pending Resolution at 
end of year
Remark
Working Conditions
0
0
0
0
0
-
Health and Safety
0
0
0
0
0
-
14.	 Assessments for the year:
% of your plants and offices that were assessed  
(by entity or statutory authorities or third parties)
Health and safety practices
100%
Working Conditions
100%
	
Note: Periodic internal audits of laboratories are conducted by internal teams. Further, accreditation bodies such as NABL 
(National Accreditation Board for Testing and Calibration Laboratories) evaluate the labs’ working conditions and health 
and safety practices as part of their accreditation process
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
100
15.	 Provide details of any corrective action taken or underway to address safety-related incidents (if any) and on 
significant risks / concerns arising from assessments of health & safety practices and working conditions.
	
All incidents are investigated to identify any gaps and make recommendations for system or process improvement. The 
objective is to learn and prevent recurring shortcomings. The recommendations are implemented in a time bound manner. 
Dissemination of safety related information and training is ensured to prevent recurrence. To ensure the effectiveness of 
all safety system components and activities, both internal and external audits are carried out as per details provided in 
the description of Safety Management System. Strict monitoring of the audit recommendations is carried out at various 
levels. Guidelines on compliance with these recommendations have been implemented across all divisions.
Leadership Indicators 
1.	
Does the entity extend any life insurance or any compensatory package in the event of death of (A) Employees 
(Y/N) (B) Workers (Y/N).
	
Yes, the company has taken term insurance for all employees.
2.	
Provide the measures undertaken by the entity to ensure that statutory dues have been deducted and deposited 
by the value chain partners.
	
The Company ensures that statutory dues as applicable to the transactions within its remit are deducted and deposited in 
accordance with extant regulations. These processes are regularly reviewed as part of both internal and statutory audit.
3.	
Provide the number of employees / workers having suffered high consequence work related injury / ill-health / 
fatalities (as reported in Q11 of Essential Indicators above), who have been rehabilitated and placed in suitable 
employment or whose family members have been placed in suitable employment:
Total Number of affected employees/ workers
No. of employees/ workers that are rehabilitated 
or whose family member have been placed in 
suitable employment
FY 2022-23
FY 2021- 22
FY 2022-23
FY 2021- 22
Employees
0
0
0
0
Workers
-
-
-
-
4.	
Does the entity provide transition assistance programs to facilitate continued employability and the management 
of career endings resulting from retirement or termination of employment? (Yes/ No):
	
Yes The company provides transition programs to facilitate continued employability and management of career ends 
resulting from retirement or termination of employment, by providing professional counseling helpline, which employee 
can access for guidance and support during their transition period. This helpline is designated to assist employee in 
navigating career challenges, exploring new opportunities and addressing any concern or challenges they may encounter 
during the retirement or termination process.
5.	
Details on assessment of value chain partners:
% of value chain partners (by value of business done with such partners) that were 
assessed
Health and safety practices
As of now, the Company does not have a process to cover assessment of value chain partners 
on these parameters. However, the Company shall strive to initiate the assessment program 
going forward based on materiality.
Working Conditions
6.	
Provide details of any corrective actions taken or underway to address significant risks /concerns arising from 
assessments of health and safety practices and working conditions of value chain partners.
	
No corrective action plan has been necessitated on the above-mentioned parameters. However, in case any such risks/ 
concerns are observed, the Company may provide a reasonable timeframe for compliance to value chain partners. On a 
case‑to-case basis, the Company may evaluate the respective risks/ concerns and may call for a corrective action plan 
from the value chain partners.
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
101
PRINCIPLE 4: Businesses should respect the interests of and be responsive to all its stakeholders
Essential Indicators 
1.	
Describe the processes for identifying key stakeholder groups of the entity.
	
The modern concept of corporate governance is to take care of welfare of not only the shareholders, but all the stake-
holders and the overall community as a whole. True to this concept, Thyrocare takes care to structure its business policies 
in such a way that they are beneficial to all the stake-holders – Investors, Employees, Customers, Vendors, Business 
Associates, and to the Society at large, and particularly the weaker sections of the society. The Company’s pricing policy 
is based on the principle of taking the company’s services within the reach of common man. Our approach towards 
responsible and sustainable business practice involves assessing the level of influence and impact of various stakeholder 
groups on the Company considering the vision and mission statement of the Company.
2.	
List stakeholder groups identified as key for your entity and the frequency of engagement with each stakeholder 
group.
Stakeholder 
Group
Whether 
identified as 
Vulnerable & 
Marginalized 
Group (Yes/No)
Channels of communication 
(Email, SMS, Newspaper, 
Pamphlets, Advertisement, 
Community Meetings, Notice 
Board, Website), Other
Frequency of 
engagement 
(Annually/ Half yearly/ 
Quarterly / others – 
please specify)
Purpose and scope of engagement 
including key topics and concerns 
raised during such engagement
Investors &
Shareholders
No
We interact with our shareholders, 
potential investors and research 
analysts 
through 
investor 
meetings/ 
calls, 
conferences, 
earnings call, investor events, 
e-mail, press releases, stock 
exchange intimations, investor 
presentations and annual reports.
Monthly/Quarterly/Half 
yearly/Yearly
Interacting 
with 
investors 
and 
shareholders increases transparency 
and accountability and helps them 
to take an informed decision to 
invest in our Company. The key 
areas of engagement includes an 
update on the business and financial 
performance, Company’s strategy and 
growth levers, potential opportunities 
and risks, material events which may 
have a positive or negative impact on 
the performance of the Company
Employees
No
By way of digital as well as physical 
channels 
of 
communication 
including 
e-mails, 
townhalls, 
newsletters, pulse surveys for 
employee feedback, redressal, 
training programmes for personal 
and professional growth.
Weekly/Monthly
Promoting transparency fostering a 
positive workplace culture improving 
diversity and inclusion. Providing 
learning 
opportunities 
to 
the 
employees to upgrade their skills.
Customers
No
Phone calls, email, live chat, 
social media, SMS, Newspaper, 
Pamphlets, Website, in peron 
meetings.
Monthly/Quarterly/Half 
yearly/Yearly
To improve customer satisfaction, 
increase customer loyalty, increase 
sales, promoting various schemes.
Vendors
No
Digital Meetings / In person 
meetings
Frequent and need 
based
Our regular updates to businesses 
encompass 
information 
about 
performance feedback, as well as 
any updates regarding changes in 
regulations related to supplies and 
services.
Govt/
Regulatory
Authorities
No
Interactions with authorities take 
place through e-mails, meetings, 
submissions, etc. as required
Need-based
Our interaction with official authorities 
serves 
multiple 
purposes. 
When 
engaging with regulatory authorities, 
our goal is to meet our obligations 
and advance our core business 
activities, in accordance with the 
highest standards of compliance 
and governance. Our engagement 
with policy makers is focused on 
gaining a deeper understanding of 
and participating in discussions about 
issues relevant to the industry.
Communities
No
Meetings, digital channels
Frequent and need 
based
Developmental / Educational needs as 
part of the Company’s CSR obligation.
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
102
Leadership Indicators 
1.	
Provide the processes for consultation between stakeholders and the Board on economic, environmental, and 
social topics or if consultation is delegated, how is feedback from such consultations provided to the Board.
	
The CSR committee generally conducts initial consultations on ESG through functional heads, while the relevant functional 
head or executive team is responsible for consulting with the respective stakeholder group. The discussions are then 
taken up at the Board meetings in accordance with the criticality of the matter.
2.	
Whether stakeholder consultation is used to support the identification and management of environmental, and 
social topics (Yes / No). If so, provide details of instances as to how the inputs received from stakeholders on these 
topics were incorporated into policies and activities of the entity.
	
Yes. Stakeholder consultation is key to identification of areas of improvement in corporate ESG efforts.
	
For example: (i) While undertaking CSR activities, stakeholder consultation & feedback is taken. (ii) Thyrocare continuously 
undertakes measures to improve its services like reducing turnaround time, ensuring accurate test report delivery, modified 
its tagline to accurately represent the business and services provided by the Company and more.
3.	
Provide details of instances of engagement with, and actions taken to, address the concerns of vulnerable/ 
marginalized stakeholder groups.
	
We have taken several steps to fulfill our Corporate Social Responsibility (CSR) obligations. These initiatives include 
providing education to underprivileged individuals, organizing a women’s health conference focused on cancer and 
thyroid disorders, for marginalized sections of communities.
PRINCIPLE 5: Businesses should respect and promote human rights
Essential Indicators 
Thyrocare is conscious of the fact that it is the responsibility of every business enterprise to respect human rights, to avoid 
infringing on the human rights of others, and to take effective remedial measures in the event of any such infringement. 
Therefore, Thyrocare takes efforts to ensure that its activities or business relationships do not cause any adverse impact on 
any community.
1.	
Employees and workers who have been provided training on human rights issues and policy(ies) of the entity, in 
the following format:
Category
FY 2022-23
FY 2021-22
Total (A)
No. of employees 
/ workers 
covered (B)
% (B / A)
Total (C)
No. of employees 
/ workers 
covered (D)
% (D / C)
Employees
Permanent
1645
954
58%
2041
1299
63%
Other than permanent
-
-
-
-
-
-
Total Employees
1645
954
58%
2041
1299
63%
Workers
Permanent
-
-
-
-
-
-
Other than permanent
-
-
-
-
-
-
Total Employees
-
-
-
-
-
-
2.	
Details of minimum wages paid to employees and workers, in the following format:
Category
FY 2022-23 
Current Financial Year
FY 2021-22 
Previous Financial Year
Total (A)
Equal to  Minimum 
Wage
More than Minimum 
Wage
Total (D)
Equal to Minimum 
Wage
More than Minimum 
Wage
No. (B)
% (B / A)
No. (C)
% (C / A)
No. (E)
% (E / D)
No. (F)
% (F / D)
Employees
Permanent
Male
1306
0
0
1306
100%
1466
0
0
1466
100%
Female
407
0
0
407
100%
575
0
0
575
100%
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
103
Category
FY 2022-23 
Current Financial Year
FY 2021-22 
Previous Financial Year
Total (A)
Equal to  Minimum 
Wage
More than Minimum 
Wage
Total (D)
Equal to Minimum 
Wage
More than Minimum 
Wage
No. (B)
% (B / A)
No. (C)
% (C / A)
No. (E)
% (E / D)
No. (F)
% (F / D)
Other than Permanent
Male
-
-
-
-
-
-
-
-
-
-
Female
-
-
-
-
-
-
-
-
-
-
Workers
Permanent
Male
-
-
-
-
-
-
-
-
-
-
Female
-
-
-
-
-
-
-
-
-
-
Other than Permanent
Male
-
-
-
-
-
-
-
-
-
-
Female
-
-
-
-
-
-
-
-
-
-
3.	
Details of remuneration/salary/wages, in the following format:
Male
Female
Number
Median remuneration/ 
salary/ wages of 
respective category
Number
Median remuneration/ 
salary/ wages of 
respective category
Board of Directors (BoD)*
1
3,18,01,079
0
-
Key Managerial Personnel**
2
60,04,064
0
-
Employees other than BoD and KMP
1306
2,64,680
407
2,59,803
Workers
-
-
-
-
	
   * BoD represents data for Managing Director and CEO only since rest of the BoD consists Non-Executive Directors
  	
  **Key Managerial Personnel include CFO and Company Secretary.
4.	
Do you have a focal point (Individual/ Committee) responsible for addressing human rights impacts or issues 
caused or contributed to by the business? (Yes/No)
	
Yes.
5.	
Describe the internal mechanisms in place to redress grievances related to human rights issues:
	
The Company has an automated Grievance Redressal Mechanism for reporting and ensuring effective redressal of any 
type grievances by the employees. This is inbuilt in the HR tool named as Darwinbox, wherein any employee can raise 
and seek redressal of grievance. The grievances are reported to HR directly.
6.	
Number of Complaints on the following made by employees and workers:
Current Financial Year 2022-23
Previous Financial Year 2021-22
Filed during 
the year
Pending 
resolution at 
end of year
Remark
Filed during 
the year
Pending 
resolution at 
end of year
Remark
Sexual Harassment
0
0
0
0
0
0
Discrimination at workplace
0
0
0
0
0
0
Child Labour
0
0
0
0
0
0
Forced Labour/ Involuntary Labour
0
0
0
0
0
0
Wages
0
0
0
0
0
0
Other human rights related issues
0
0
0
0
0
0
7.	
Mechanisms to prevent adverse consequences to the complainant in discrimination and harassment cases.
	
The Company has implemented a Whistle Blower policy which allows employees to report to any improper activities that 
may lead to violation of laws, rules, regulation or breach of code of conduct including misuse of price sensitive information, 
to the competent authority or Chairperson of the Audit Committee. As per Whistle Blower Policy, the Company ensure 
the protection of complaints, and if required, the investigation is to be conducted in a confidential manner, ensuring the 
protection of the complainant and safeguarding against any retaliation. The contact details of the Chairperson of Audit 
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
104
Committee have been provided in the Company’s website for information of the employees. Additionally, the company has 
established an internal complaints committee and mechanism for redressal of a complaint related to sexual harassment 
under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013. The Company 
provides training/awareness session for all employees relating to all policies and regulations including those related to 
prevention of sexual harassment, prevention of child labour etc.
8.	
Do human rights requirements form part of your business agreements and contracts? (Yes/No)
	
No
9.	
Assessments for the year:
% of your plants and offices that were assessed (by entity or statutory authorities or third parties)
Child labour
No case was reported during financial year 2022-23. The Company’s systems have inbuilt checks to 
prevent any hiring of employee who is less than 18 years of age.
Forced/involuntary labour
No case was reported during financial year 2022-23.
Sexual harassment
All cases of sexual harassment are handled by the respective committees and the reports are submitted 
to the management. The annual report of the Company published each year has the details on the cases, 
if any, received and their redressal.
Discrimination at workplace No case was reported during financial year 2022-23.
Wages
No case was reported during financial year 2022-23. Additionally, the compliance of minimum wage 
requirement is audited by the Statutory as well as the Internal auditors.
Others – please specify
10.	 Provide details of any corrective actions taken or underway to address significant risks / concerns arising from 
the assessments at Question 9 above.
	
Not applicable
Leadership Indicators 
1.	
Details of a business process being modified / introduced as a result of addressing human rights grievances/
complaints.
	
The Company has defined process for addressing grievances relating to any right of the employees, which it believes is 
currently working properly. The Company may relook at its processes in future, should the circumstances/particulars of 
a case calls for.
2.	
Details of the scope and coverage of any Human rights due-diligence conducted.
	
The Company has not conducted any Human Rights due-diligence for the financial year ended March 31, 2023. However, 
the Company may consider doing the same in the current financial year, depending on circumstances/instances/materiality.
3.	
Is the premise/office of the entity accessible to differently abled visitors, as per the requirements of the Rights of 
Persons with Disabilities Act, 2016?
	
Yes
4.	
Details on assessment of value chain partners:
% of value chain partners (by value of business done with such partners) that were 
assessed
Sexual Harassment
As of now, the Company does not have a process to cover assessment of value chain 
partners on these parameters. However, the Company shall strive to initiate the assessment 
program going forward.
Discrimination at workplace
Child Labour
Forced Labour/Involuntary Labour
Wages
Others – please specify
5.	
Provide details of any corrective actions taken or underway to address significant risks / concerns arising from 
the assessments at Question 4 above.
	
Not Applicable, since there were no cases observed on the above
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
105
PRINCIPLE 6: Businesses should respect and make efforts to protect and restore the environment
Essential Indicators 
Thyrocare is fully aware that protecting the environment around us is of vital importance for our well being. Any damage to 
the environment ultimately endangers the very existence of life itself in the long run. Therefore, Thyrocare is taking all possible 
efforts to prevent any kind of pollution and adhering to the best procedures to protect the environment. Apart from complying 
with the statutory regulations, Thyrocare has structured Standard Operating Procedures to ensure that the Company’s activities 
do not create any negative impact on the environment.
1.	
Details of total energy consumption (in Joules or multiples) and energy intensity, in the following format:
(in joules )
Parameter
FY 2022-23
FY 2021-22
Total electricity consumption (A)
2.28
2.08
Total fuel consumption (B)
1.99
1.75
Energy consumption through other sources (C)
1.84
1.75
Total energy consumption (A+B+C)
6.11
5.58
Energy intensity per rupee of turnover (Total energy consumption/ turnover in rupees)
1.1095
1.0132
Energy intensity per rupee of turnover in Gigajoules (GJ)/ INR Million
-
-
Whether any independent assessment/ evaluation/assurance has been carried out 
by an external agency? (Y/N) If yes, name of the external agency. 
NO
NO
2.	
Does the entity have any sites / facilities identified as designated consumers (DCs) under the Performance, Achieve 
and Trade (PAT) Scheme of the Government of India? (Y/N) If yes, disclose whether targets set under the PAT 
scheme have been achieved. In case targets have not been achieved, provide the remedial action taken, if any.
	
No
3.	
Provide details of the following disclosures related to water, in the following format:
Parameter
FY 2022-23
FY 2021-22
Water withdrawal by source (in kilolitres)
(i) 	
Surface water
NA
NA
(ii) 	
Groundwater
NA
NA
(iii) 	 Third party water
34178
33518
(iv) 	 Seawater / desalinated water
NA
NA
(v) 	 Others
NA
NA
Total volume of water withdrawal (in kilolitres)
34178
33518
Total volume of water consumption (in kilolitres)
34178
33518
Water intensity per rupee of turnover (Water consumed / turnover) (KL per rupee)
7.42
6.08
4.	
Has the entity implemented a mechanism for Zero Liquid Discharge? If yes, provide details of its coverage and 
implementation
	
The Company has installed Sewage Treatment Plant at its corporate office. This plant effectively treats the wastewater 
generated on-site and the treated (recycled) wastewater is being used for day to day purposes such as toilet flush. 
Additionally, all the labs within the Company have their own effluent treatment plants installed to ensure proper treatment 
of wastewater before it is discharged from the labs.
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
106
5.	
Please provide details of air emissions (other than GHG emissions) by the entity, in the following format:
Parameter
Please specify unit
FY 2022-23
FY 2021-22
NOx
NA
NA
NA
SOx (Kg/Day)
NA
NA
NA
Particulate matter (PM) (PPM)
NA
NA
NA
Persistent organic pollutants (POP)
NA
NA
NA
Volatile organic compounds (VOC)
NA
NA
NA
Hazardous air pollutants (HAP)
NA
NA
NA
Others – ODS
NA
NA
NA
Note: Being in the service industry, the Company’s only source of air emissions is the use of diesel generators at 25 labs and office 
units. All of these generators are regularly maintained and operate within permissible emission limits.
6.	
Provide details of greenhouse gas emissions (Scope 1 and Scope 2 emissions) & its intensity:
Parameter
Please specify unit
Current Financial 
Year 2022-23
Previous Financial 
Year 2021- 22
Total Scope 1 Emissions (Break-up of the GHG into CO2, 
CH4, N2O, HFCs, PFCs, SF6, NF3, if available)
NA
NA
NA
Total Scope 2 Emissions
(Break-up of the GHG into CO2, CH4, N2O, HFCs, PFCs, 
SF6, NF3, if available)
NA
NA
NA
Total Scope 1 and Scope 2 emissions per rupee of turnover
NA
NA
NA
Total Scope 1 and Scope 2 emission intensity (optional)- the 
relevant metric may be selected by the entity
NA
NA
NA
	
  Note: The Company operates in the service sector, hence the likelihood that it will emit GHGs is either negligible or non existent.
7.	
Does the entity have any project related to reducing Green House Gas emission? If Yes, then provide details.
	
No, the Company operates in the service sector, the likelihood that it will emit GHGs is very low or non existent.
8.	
Provide details related to waste management by the entity, in the following format:
Parameter
Current FY 2022-23
Previous FY 2021-22
Total Waste generated (in tonnes)
Plastic waste (A)
237.4 T
241.9 T
E-waste (B)
NA
NA
Bio-medical waste (C)
175.3 T
112.6 T
Construction and demolition waste (D)
NA
NA
Battery waste (E)
NA
NA
Radioactive waste (F)
NA
NA
Other Hazardous waste. Please specify, if any. (G)
NA
NA
Other Non-hazardous waste generated (H). Please specify, if any. (Break-up by 
composition i.e. by materials relevant to the sector)
NA
NA
Total (A+B + C + D + E + F + G + H)
412.7882 T
354.53034 T
For each category of waste generated, total waste recovered through recycling, re-
using or other recovery operations (in tonnes)
Category of waste (Add columns, if necessary)
NA
NA
(i) 	
Recycled
237.4 T
241.9 T
(ii) 	
Re-used
NA
NA
(iii) 	 Other recovery operations
NA
NA
Total
NA
NA
For each category of waste generated, total waste disposed by nature of 
disposal method (in tonnes)
Category of waste (Add columns, if necessary)
(i) 	
Incineration
NA
NA
(ii) 	
Landfilling
NA
NA
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
107
Parameter
Current FY 2022-23
Previous FY 2021-22
(iii) 	 Other disposal operations
i.e. handing over of bio medical waste to authorised service provider for further 
processing
175.3 T
112.6 T
Recycling of plastic waste by third party
237.4 T
241.9 T
Total
412.78 T
354.53 T
9.	
Briefly describe the waste management practices adopted in your establishments. Describe the strategy adopted 
by your company to reduce usage of hazardous and toxic chemicals in your products and processes and the 
practices adopted to manage such wastes:
	
The waste is segregated as per the following codes:
	
- Red
	
- Yellow
	
- Blue
	
- Black.
	
Afterwards, Red and Yellow wastes are then pre-treated (using autoclave).
	
The bio-medical wastes produced in the laboratory are handed over to the State Pollution Control Board for recycling or 
safe disposal in accordance with the provisions of the Bio-Medical Waste Management Rules 2016. The Company has 
formulated Standard Operating Procedures for waste management, to ensure proper separation, handling, storage and 
transportation of bio-medical wastes.
10.	 If the entity has operations/offices in/around ecologically sensitive areas (such as national parks, wildlife 
sanctuaries, biosphere reserves, wetlands, biodiversity hotspots, forests, coastal regulation zones etc.) where 
environmental approvals / clearances are required, please specify details in the following format:
S. No.
Location of operations/ 
offices
Type of operations
Whether the conditions of environmental approval/ clearance are 
being complied with? (Yes/No) If “No”, the reasons thereof and 
corrective action taken, if any.
None of our labs or offices are located in ecologically sensitive sites.
11.	 Details of environmental impact assessments of projects undertaken by the entity based on applicable laws, in 
the current financial year:
Name and brief of the 
project
EIA Notification No.
Date
Whether conducted 
by independent 
agency (Yes/No)
Results communicated 
in public domain (Yes/
No)
Relevant
Web-link
None
	
The entity has not conducted any environmental impact assessments. However, we have implemented eco-friendly 
practices in our labs and our corporate office. This includes the installation of solar panels in three labs and our 
registered office.
	
Additionally, 25 labs have ETP installed. We also prioritize employees’ training and education on energy and resources 
conservation methods to ensure reasonable usage.
12.	 Is the entity compliant with the applicable environmental law/ regulations/ guidelines in India; such as the Water 
(Prevention and Control of Pollution) Act, Air (Prevention and Control of Pollution) Act, Environment protection act 
and rules thereunder (Y/N). If not, provide details of all such non-compliances, in the following format:
S. No.
Specify the law/ regulation/ 
guidelines which is not 
compliant
Provide details of the 
non-compliance
Any fines/ penalties/ action taken 
by regulatory agencies such as 
pollution control board or by courts
Corrective action taken, 
if any
None
	
Note: The Company follows all the applicable environmental law/ regulations/ guidelines in India.
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
108
Leadership Indicators 
1.	
Provide break-up of the total energy consumed (in Joules or multiples) from renewable and non-renewable sources, 
in the following format:
Parameter
Current FY 2022-23
Previous FY 2021-22
From renewable sources
Total electricity consumption (A)
0
0
Total fuel consumption (B)
0
0
Energy consumption through other sources (C)
1.84
1.75
Total energy consumed from renewable sources (A+B+C)
1.84
1.75
From non-renewable sources
Total electricity consumption (D)
2.20
2.08
Total fuel consumption (E)
1.99
1.75
Energy consumption through other sources (F)
0
0
Total energy consumed from non-renewable sources (D+E+F)
4.19
3.83
2.	
Provide the following details related to water discharged:
Parameter
Current Financial 
Year 2022-23
Previous Financial 
Year 2021-22
Water discharge by destination and level of treatment (in kilo-litres)
(i)	
To Surface Water
No treatment
0
0
With treatment- please specify level of treatment
0
0
(ii)	
To Ground Water
No treatment
0
0
With treatment- please specify level of treatment
0
0
(iii)	
To Seawater
No treatment
0
0
With treatment- please specify level of treatment
0
0
(iv)	
Sent to Third Parties
No treatment
0
0
With treatment- please specify level of treatment
0
0
(v)	
Others
No treatment
0
0
With treatment- please specify level of treatment
0
0
Total water discharged (in kilo-litres)
3.	
Water withdrawal, consumption and discharge in areas of water stress (in kilolitres):
	
Each facility/ plant located in areas of water stress, provide the following information:
	
i.	
Name of area
	
ii.	
Nature of operations
	
iii.	
Water withdrawal, consumption, and discharge in the following format:
Parameter
Current Financial 
Year 2022-23
Previous Financial 
Year 2021-22
Water withdrawal by source (in kilo litres)
(i)	
Surface Water
-
-
(ii)	
Ground Water
-
-
(iii)	
Third Party Water
-
-
(iv)	
Seawater/ Desalinated Water
-
-
(v)	
Others
-
-
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
109
Parameter
Current Financial 
Year 2022-23
Previous Financial 
Year 2021-22
Total volume of water withdrawal (in KL)
-
-
Total volume of water consumption (in KL)
-
-
Water intensity per rupee of turnover (water consumed/ turnover)
-
-
Water intensity (optional)- the relevant metric may be selected by the entity
-
-
Water discharge by destination and level of treatment (in Kilo litres)
(i)	
To Surface Water
-
-
No treatment
-
-
With treatment- please specify level of treatment
-
-
(ii)	
To Ground Water
-
-
No treatment
-
With treatment- please specify level of treatment
-
-
(iii)	
Sent to Third Party Water
-
-
No treatment
-
-
With treatment- please specify level of treatment
-
-
(iv)	
Into Seawater
-
-
No treatment
-
-
With treatment- please specify level of treatment
-
-
(v)	
Others
-
-
No treatment
-
-
With treatment- please specify level of treatment
-
-
	
   Note: All our labs are in Commercial area and MIDC area.
4.	
Please provide details of total Scope 3 emissions & its intensity, in the following format:
Parameter
Please 
specify unit
Current Financial 
Year 2022-23
Previous Financial 
Year 2021- 22
Total Scope 3 Emissions (Break-up of the GHG into CO2, CH4, N2O, 
HFCs, PFCs, SF6, NF3, if available)
-
-
-
Total Scope 3 emissions per rupee of turnover
-
-
-
Total Scope 3 emission intensity (optional)- the relevant metric may be 
selected by the entity
-
-
-
Note: The possibility of air emissions being remitted in the atmosphere, 
considering the business that the Company is in, may arise only on 
account of the DG (Diesel Generator) sets that the Company uses 
at its Laboratories. The Company, as a first and during the Financial 
Year 2022-23 took proactive measures to prevent the release of 
polluting radiations into atmosphere. The Company also tested all its 
DG sets having KVA> 100 load from the State Pollution Control Board 
empaneled agency. The testing reports confirmed that emissions from 
all DG sets were within the permissible limits.
5.	
With respect to the ecologically sensitive areas reported at Question 10 of Essential Indicators above, provide 
details of significant direct & indirect impact of the entity on biodiversity in such areas along-with prevention and 
remediation activities:
	
Not applicable
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
110
6.	
If the entity has undertaken any specific initiatives or used innovative technology or solutions to improve resource 
efficiency, or reduce impact due to emissions / effluent discharge / waste generated, please provide details of the 
same as well as outcome of such initiatives, as per the following format:
S.No.
Initiative undertaken
FY 2022-23
Details of the initiative (Web-link, if any, may 
be provided along-with summary)
Outcome of the initiative
1
STP plant
Our company has installed a Sewage 
Treatment Plant at the corporate office. The 
wastewater is treated at the Sewage Treatment 
Plant, and the cleaned water has been reused.
Reduction in usage of clean water sourced from 
government bodies.
2
ETP plant
25 labs out of 29 have Effluent Treatment Plant 
installed. These Effluent Treatment Plant treats 
the effluent water and then the water has been 
discharged.
Successful treatment of effluent before discharge 
by the Company
3
Solar panel
Three labs and registered office have solar 
panels installed.
This has led to usage of renewable source of 
energy thereby reducing the reliance of traditional 
sources of energy.
7.	
Does the entity have a business continuity and disaster management plan? Give details in 100 words/ web link.
	
The emergency plan ensures safety and well-being of our facility. For fire emergencies, we have installed fire extinguishers, 
smoke detectors & hydrant systems and conduct regular mock-drill training sessions. Floor Marshals are trained to 
manage and assist in such situations. Backup DG sets and UPS systems help maintain power supply in case of power 
outage. We have safety showers, eye wash stations, PPEs, spill kits, and first aid boxes in event of chemical and biological 
spillage. Medical emergencies are handled by making first aid supplies and doctor consultation available. PA systems, 
fire extinguishers, first aid supplies, and evacuation plans are in place to manage earthquakes and floods. We ensure 
the safety and well-being in emergency situations by making adequate arrangements for accommodation, food and 
medical support.
8.	
Percentage of value chain partners (by value of business done with such partners) that were assessed for 
environmental impacts.
	
As of now, the BRSR principles cover only the Company. The Company shall strive to include its Value Chain Partners to 
measure and mitigate any potential environmental impact going forward.
PRINCIPLE 7: Businesses, when engaging in influencing public and regulatory policy, should do so in a 
manner that is responsible and transparent
Essential Indicators 
Though collaborating with similar businesses and representing to the Government for redressal of common grievances is 
recognised as an acceptable business practice, it is the policy of Thyrocare that any engagement with the Government should 
be for the welfare of the public at large and should not be with the intention of advancing the interests or promoting the welfare 
of a select few.
1.	
a.	
Number of affiliations with trade and industry chambers/ associations.
	
b.	
List the top 10 trade and industry chambers/ associations (determined based on the total members of such 
body) the entity is a member of/ affiliated to.
S. No.
Name of the trade and industry chambers/ 
associations
Reach of trade and industry chambers/ associations 
(State/National)
1
Confederation of Indian Industry National
National
2.	
Details of public policy positions advocated by the entity:
S. No.
Public policy 
advocated
Method resorted for 
such advocacy
Whether information 
available in public 
domain (Yes/No)
Frequency of Review 
by Board
Web Link, if available
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
111
Leadership Indicators 
1. 	
Details of public policy positions advocated by the entity:
	
The Company has not advocated any influence over regulatory processes regarding public policy.
S. No.
Public policy 
advocated
Method resorted for 
such advocacy
Whether information 
available in public 
domain (Yes/No)
Frequency of Review 
by Board
Web Link, if available
PRINCIPLE 8: Businesses should promote inclusive growth and equitable development
Essential Indicators 
Thyrocare believes that real growth and development can be achieved only when equal opportunities are made available to 
every member of the society and there is equitable development; a lopsided growth will ultimately lead to social unrest and 
result in negation of the benefits already achieved. Therefore, Thyrocare formulates its policies in such a way that the benefits 
of its services are easily available to everyone. Thyrocare has also structured its CSR policies on the principle of empowering 
and enabling the community as a whole to participate in the march towards growth and development.
1.	
Details of Social Impact Assessments (SIA) of projects undertaken by the entity based on applicable laws, in the 
current financial year.
Name and brief 
detail of project
SIA Notification No.
Date of 
notification
Whether conducted by 
independent external 
agency (Yes/ No)
Results communicated 
in public domain (Yes/
No)
Relevant web-
link
None
2.	
Provide information on project(s) for which ongoing Rehabilitation and Resettlement (R&R) is being undertaken 
by your entity, in the following format:
S. No. 
Name of the project for 
which R&R is ongoing 
State 
District 
No. of project affected 
families (PAFs) 
%of PAFs 
covered by R&R
Amounts paid to PAFs 
in the FY (in INR.)
None
3.	
Describe the mechanisms to receive and redress grievances of the community.
	
Any Community member can raise their concerns on business responsibility and sustainability-related topics by writing 
a letter addressed to Mr. Rahul Guha, Managing Director and Chief Executive Officer and posting it to below address:
	
Thyrocare Technologies Limited
	
D/37-3, TTC Industrial Area, MIDC,
	
Turbhe, Navi Mumbai - 400 703.
	
Such concerns will be taken up with concerned departments to initiate necessary actions basis its significance.
4.	
Percentage of input material (inputs to total inputs by value) sourced from suppliers:
Current FY 2022-23
Previous FY 2021-22
Directly sourced from MSMEs/ small producers
21.55%
16.01%
Sourced directly from within the district and neighboring districts
Company will track and publish this number 
going forward
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
112
PRINCIPLE 9: Businesses should engage with and provide value to their consumers in a responsible manner
Essential Indicators 
Thyrocare has always considered the customer as the focal point for all its business decisions and its avowed Mission is to 
ensure that the highest value is given to the patient at the right time and at the least cost. High productivity, lean operations, 
able administration and volume-enabled savings have made Thyrocare one of the affordable Clinical Chemistry Laboratory 
in the nation.
1.	
Describe the mechanisms in place to receive and respond to consumer complaints and feedback.
	
The Company has not implemented a formal Grievance Redressal Policy; however, customers can make their complaints 
to the Company through following channels:
	
1)	
By writing an email to complaints@thyrocare.com;
	
2)	
By making a call to the helpline numbers at 022 30900000/67123400; and
	
3)	
By sending a message through whatsapp on 9870666333.
	
Upon receiving a complaints, the process is initiated and assigned to the relevant stakeholders group for redressal. 
Standard Turnaround Time (TAT) for closure of any complaint is 24 to 48 hours.
	
The escalation matrix for complaint redressal is as follows:
	
Level 1 : redressals@thyrocare.com;
	
Level 2: gm.redressals@thyrocare.com
	
After a complaint has been resolved, customers are requested to provide feedback on their satisfaction/dissatisfation 
with the compliant redressal through email. If a customer selects “Not-satisfied”, the complaint is re-opened and entire 
process will be followed again.
2.	
Turnover of products and/ services as a percentage of turnover from all products/service that carry information 
about:
As a percentage to total turnover
Environmental and social parameters relevant to the product
Not applicable-
Safe and responsible usage
Not applicable-
Recycling and/or safe disposal
-
	
The Company offers diagnostic services. It is not in the business of manufacturing/selling products. Hence, being party 
to the information on environmental and social parameters/safe usage or disposal is not applicable for it.
3.	
Number of consumer complaints in respect of the following:
Current FY 2022-23
Remarks
Previous FY 2021-22
Remarks
Received 
during the 
year
Pending 
resolution at 
end of year
Received 
during the 
year
Pending 
resolution at 
end of year
Data privacy
0
0
-
0
0
-
Advertising
0
0
-
0
0
-
Cyber-security
0
0
-
0
0
-
Delivery of essential services
0
0
-
0
0
-
Restrictive Trade Practices
0
0
-
0
0
-
Unfair Trade Practices
0
0
-
0
0
-
Others
24787
40*
4266
31**
	
   Note:
	
   * *All complaints were closed as on April 15, 2023
	
    ** All complaints were closed as on April 20, 2023
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
113
4.	
Details of instances of product recalls on account of safety issues:
Number
Reasons for recall
Voluntary recalls
208,800
Fasting Not maintained, Not Available Today, Another Time Request
Forced recalls
508
Hand gloves not in spare, Dress-Code Not followed, Not Carried Sanitizer, Mask 
Adherence compromised
	
Note: The Company operates in the service sector for provision of diagnostic services, hence as such there are no product 
recalls. The details of recalls mentioned are related to service related recalls. Voluntary recalls of services are generally on 
accounts of non-adherence to pre-requisites of tests (eg: fasting), customer requests, etc. Forced recalls are to maintain 
highest service standards.
5.	
Does the entity have a framework/ policy on cyber security and risks related to data privacy? (Yes/No) If available, 
provide a web-link of the policy.
	
Yes, the Company has a policy on cyber security and risk related to data privacy, which is available on the Company’s 
website at https://www.thyrocare.com/PrivacyPolicy.
6.	
Provide details of any corrective actions taken or underway on issues relating to advertising, and delivery of 
essential services; cyber security and data privacy of customers; re-occurrence of instances of product recalls; 
penalty / action taken by regulatory authorities on safety of products / services.
	
During the financial year 2022-23, there have not been any material instances of issues relating to advertising, and delivery 
of essential services, cyber security and data privacy of customers, re-occurrence of instances of product recalls, penalty 
/ action taken by regulatory authorities on safety of products / services.
Leadership Indicators 
1.	
Channels / platforms where information on products and services of the entity can be accessed (provide web link, 
if available)
	
The information about services offered by the Company can be accessed through the following platforms:
	
1.	
Company Website - www.thyrocare.com
	
2.	
Thyrocare mobile application which is available both on Google play store and Apple App store
	
3.	
Third party associates through with our products/services are sold:
	
	
n	
1MG (www.1mg.com/labs)
	
	
n	
Mfine (App/www.fine.co)
	
	
n	
Medibuddy (www.medibuddy.in)
	
	
n	
Book Meri Lab (www.bookmerilab.com)
	
	
n	
Health care on time (www. healthcareontime.com)
	
4.	
By walk-in in any our nearest associated collection centre
	
5.	
By calling on our helpline i.e. 022 30900000/67123400 or writing to - customersupport@thyrocare.com / wellness@
thyrocare.com
2.	
Steps taken to inform and educate consumers about safe and responsible usage of products and/or services.
	
The Company operates in the sector of providing diagnostic services. Necessary pre-requisites of tests like fasting 
requirement, type of sample, quantity of sample are communicated to customers before sample collection/at the time 
of booking.
	
Informational messages on symptoms of diseases, types of tests and health awareness, etc. are displayed on the social 
media pages of the Company from time to time.
	
Details of various healthcare packages are also made available in the Company’s website, www.thyrocare.com
THYROCARE TECHNOLOGIES LIMITED
Annual Report 2022-23
114
3.	
Mechanisms in place to inform consumers of any risk of disruption/discontinuation of essential services.
	
If an appointment can’t be fulfilled or there is a delay in publishing report beyond the TAT, the customer is informed well 
in advance through a phone call and/or whatsapp communication.
4.	
Does the entity display product information on the product over and above what is mandated as per local laws? 
(Yes/No/Not Applicable) If yes, provide details in brief. Did your entity carry out any survey with regard to consumer 
satisfaction relating to the major products / services of the entity, significant locations of operation of the entity 
or the entity as a whole? (Yes/No)
	
The requirement of displaying product information on the product over and above what is mandated as per local laws is 
not applicable as the Company is in the business of providing diagnostic services.
	
The Company has not carried out any consumer survey, but has a system of getting feedback from the consumers, based 
on which appropriate actions are taken to improve the services and resolve the consumer grievances at different stages 
of service delivery:
	
The Company conducts a satisfaction survey after every transaction with the customer, and the results are analyzed to 
improve performance.
5.	
Provide the following information relating to data breaches:
	
a.	
Number of instances of data breaches along-with impact
	
	
There are no instances of data breach that have been reported during the financial year 2022-23.
	
b.	
Percentage of data breaches involving personally identifiable information of customers:
	
	
Not applicable.
 CORPORATE OVERVIEW   |   STATUTORY REPORTS   |   FINANCIAL STATEMENTS
Annual Report 2022-23
115
